We are live on ! Find out more
ME

McIlrath & Eck Portfolio holdings

AUM $1.35B
1-Year Est. Return 15.78%
This Fund
S&P 500
This Quarter Est. Return
+5.97%
1 Year Est. Return
+15.78%
3 Year Est. Return
+43.95%
5 Year Est. Return
+48.52%
10 Year Est. Return
AUM
$477M
AUM Growth
+$48.7M
Cap. Flow
+$25.1M
Cap. Flow %
5.26%
Top 10 Hldgs %
67.59%
Holding
954
New
31
Increased
105
Reduced
200
Closed
61
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
PUK icon
776
Prudential
PUK
$33B
$2.27K ﹤0.01%
80
AMLI
777
DELISTED
American Lithium Corp. Common Stock
AMLI
$2.25K ﹤0.01%
1,120
VOYA icon
778
Voya Financial
VOYA
$9.02B
$2.15K ﹤0.01%
30
SNOW icon
779
Snowflake
SNOW
$121B
$2.11K ﹤0.01%
12
FLN icon
780
First Trust Latin America AlphaDEX Fund
FLN
$43.4M
$2.11K ﹤0.01%
111
WAB icon
781
Wabtec
WAB
$47.1B
$2.08K ﹤0.01%
19
TVRD
782
Tvardi Therapeutics
TVRD
$23.1M
$2.08K ﹤0.01%
20
GDOT icon
783
Green Dot
GDOT
$756M
$2.06K ﹤0.01%
110
VONG icon
784
Vanguard Russell 1000 Growth ETF
VONG
$45.8B
$2.06K ﹤0.01%
+29
New +$1.9K
BN icon
785
Brookfield
BN
$82.7B
$1.99K ﹤0.01%
89
FSR
786
DELISTED
Fisker Inc.
FSR
$1.97K ﹤0.01%
350
WERN icon
787
Werner Enterprises
WERN
$2.17B
$1.94K ﹤0.01%
44
QLYS icon
788
Qualys
QLYS
$6.31B
$1.94K ﹤0.01%
15
HRB icon
789
H&R Block
HRB
$5.58B
$1.91K ﹤0.01%
60
ACMR icon
790
ACM Research
ACMR
$4.67B
$1.8K ﹤0.01%
138
KD icon
791
Kyndryl
KD
$2.86B
$1.79K ﹤0.01%
135
CRSP icon
792
CRISPR Therapeutics
CRSP
$5.65B
$1.74K ﹤0.01%
31
MTCH icon
793
Match Group
MTCH
$10B
$1.72K ﹤0.01%
41
-6
-13% -$219
AGZ icon
794
iShares Agency Bond ETF
AGZ
$634M
$1.71K ﹤0.01%
16
ZM icon
795
Zoom
ZM
$27.2B
$1.7K ﹤0.01%
25
MAXN
796
DELISTED
Maxeon Solar Technologies
MAXN
$1.69K ﹤0.01%
1
BXP icon
797
Boston Properties
BXP
$10.2B
$1.67K ﹤0.01%
29
HWM icon
798
Howmet Aerospace
HWM
$89.9B
$1.64K ﹤0.01%
33
TNL icon
799
Travel + Leisure Co
TNL
$3.95B
$1.61K ﹤0.01%
40
ESTC icon
800
Elastic
ESTC
$9.27B
$1.6K ﹤0.01%
25

Similar funds

McIlrath & Eck's Q2 2023 Portfolio in Review

As of Q2 2023, McIlrath & Eck held 954 positions worth $477M, up 11% from $428M the previous quarter. Its ten largest holdings account for 68% of the portfolio.

McIlrath & Eck deployed $25.1M of net new capital in Q2 2023, opening 31 new positions and adding to 105 existing holdings. Its largest new stake was iShares US Treasury Bond ETF: 164,257 shares worth $3.76M.

By sector, the portfolio is most concentrated in Miscellaneous at 78% of assets, up from 78% a quarter earlier, followed by Technology and Financials.

On the sell side, the largest reduction was Vanguard Russell 2000 ETF, an estimated $5.96M trimmed.

  • McIlrath & Eck's largest Q2 2023 buy was iShares US Treasury Bond ETF: 164,257 shares worth $3.76M.
  • McIlrath & Eck added most to Strive Emerging Markets ex-China ETF in Q2 2023, an estimated $14M increase.
  • McIlrath & Eck's biggest Q2 2023 reduction was Vanguard Russell 2000 ETF, cutting an estimated $5.96M.
  • McIlrath & Eck fully exited SPDR S&P 600 Small Cap ETF (based on S&P SmallCap 600 Index--symbol SML) in Q2 2023, selling an estimated $650K.
  • McIlrath & Eck's ten largest holdings make up 68% of its $477M portfolio in Q2 2023.
  • McIlrath & Eck opened 31 new positions and closed 61 in Q2 2023.
  • McIlrath & Eck's portfolio value rose 11% quarter-over-quarter to $477M.

Based on McIlrath & Eck's 13F filing for Q2 2023, filed 7 Aug 2023.